Featured Topic Featured Topic

Defining The Future...

Read about Elan's cutting-edge Alzheimer's disease research in "Developing New Diagnostic Approaches for Alzheimer’s Disease"

ICARA Home Page Featured Topic
Marketed Drugs Marketed Drugs
Tysabri (natalizumab)
Ongoing Clinical Trials Ongoing Clinical Trials

Alzheimer’s Disease

  • Bapineuzumab, Phase III Studies. More.
  • ELND005, Phase II Studies. More.
  • ACC-001, Phase II Study. More.

Crohn’s Disease

  • TYSABRI INFORM Study. More.
Product Pipeline Product Pipeline
Chart

Biopharmaceutical
products and pipeline.
View.

Recent News Recent News

11/17/2009: WEBCAST TODAY: Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference More.

11/06/2009: Elan and Biogen Idec Announce an Update to Tysabri Prescribing Information and Medication Guide More.

10/29/2009: Elan Corporation Plc Announces Expiration of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011 More.